CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings

LetterJune 2, 2020 Vol 141, Issue 22

JOURNAL:Circulation. Article Link

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation

SC Larsson, D Gill , AM Mason et al. Keywords: Lipoprotein(a); causal effect; CAD; valvular disease

Full Text PDF